2026 NPPES data Dermatology Physician NPI 1104182393 M.D.
Verify on CMS →

MARK BURNETT, M.D.

Dermatology Physician in SANTA BARBARA, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
364
Medicare Part D claims · 191 beneficiaries · Dermatology Physician avg: 729
Generic prescribing
96%
generic claims · 4% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
72.6626/100
▼ 10 pts below national avg 83.1 · [object Object]
Industry payments
$431.02
16 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MARK BURNETT, M.D. is a Dermatology Physician ([object Object]) practicing in SANTA BARBARA, California with a Medicare Part D prescribing footprint of 364 claims across 191 beneficiaries — 4% brand-name prescribing . Their CMS MIPS Final Score of 72.6626/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $431.02 across 16 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: MARK BURNETT, M.D. reported a CMS MIPS final score of 72.6626 out of 100, below the 83.1 national average, and filed 364 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

MARK BURNETT, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

MARK BURNETT, M.D. at a glance

Below national average

NPI registry status

Active

Issued 04/02/2012

NPI 1104182393

Primary specialty

Dermatology Physician

Mid-sized

14,610 US NPIs in this specialty

Medicare Part D claims

364 50% vs specialty avg

2023 prescription claims

Specialty avg: 729

MIPS final score

72.6626/100 10.437399999999997% pts

Mid-tier band

vs 83.1 national avg

Specialty distribution in California

How Dermatology Physician compares to other specialties among California providers

California providers

Dermatology Physician share within California

1. Dermatology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Dermatology Physician share within California

Medicare quality performance — MIPS

MARK BURNETT, M.D.'s 2023 MIPS final score plotted against the Dermatology Physician national average

Below national average
MIPS Final Score
72.6626/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Dermatology Physician) — 72.6626/100 vs national avg 83.1

0%100%National avg83%72.7%
MIPS final score (Dermatology Physician) — 72.6626/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK BURNETT, M.D. is a Dermatology Physician provider practicing in SANTA BARBARA, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1104182393. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MARK BURNETT, M.D. appears in the CMS NPPES registry as a Dermatology Physician provider holding M.D. credentials at 2323 OAK PARK LN STE 202, SANTA BARBARA, CA, 93105, with a listed phone of (805) 892-8111. NPI 1104182393 was issued on 04/02/2012. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BURNETT most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 364 prescription claims written by this provider, covering 191 Medicare beneficiaries and totaling roughly $59K in drug spend, split 4% brand-name and 96% generic by claim count, with an opioid prescribing rate of 7.4%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 72.6626/100 for the 2023 performance year (Quality 92.1536, Cost 19.337), compared with the national average of 83.1.

Dermatology Physician is a mid-sized specialty nationwide, with 14,610 enrolled providers across 53 states and an average of 729 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2323 OAK PARK LN STE 202
SANTA BARBARA, CA 93105

Provider Details

NPI 1104182393
Specialty Dermatology Physician
Credentials M.D.
Gender Male
NPI Issued 04/02/2012

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

72.6626
Final Score
Avg: 83.1
92.1536
Quality
19.337
Cost

Reporting: Group practice

Hospital and facility affiliations

Facilities where MARK BURNETT, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

CALIFORNIA DERMATOLOGY GROUP PC
SANTA BARBARA, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK BURNETT, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$431

Largest payer

SUN PHARMACEUTICAL INDUSTRIES INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to MARK BURNETT, M.D.. To verify MARK BURNETT, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

MARK BURNETT, M.D. — brand share 4.0%
Specialty average (est.)

4% brand-name claims vs 96% generic, on 364 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

364
Total Claims
$59K
Total Drug Cost
191
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
379
Total Day Supply
8,346
Brand vs Generic
4% brand / 96% generic
Brand Drug Cost
$50K
Generic Drug Cost
$9K
Opioid Claims
27 (7.4% rate)
Antibiotic Claims
46

Patient Demographics

Average Patient Age
78.4 years
Avg HCC Risk Score
1.17
Gender Split
47% female / 53% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Mupirocin
68
Clobetasol Propionate
43
Triamcinolone Acetonide
42
Hydrocortisone
29
Doxycycline Hyclate
27
Ketoconazole
23
Oxycodone Hcl
15
Dupixent Syringe
Dupilumab
12
Clindamycin Phosphate
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Dermatology Physician Overview

How MARK BURNETT, M.D. fits within the Dermatology Physician landscape nationally.

14,610
Dermatology Physician Providers in US
53
States with Dermatology Physician
729
Avg Claims per Provider

MARK BURNETT, M.D.'s 364 claims are below the specialty average of 729.

Nearby Dermatology Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as BURNETT.

Compare Dermatology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK BURNETT, M.D.'s specialty?
MARK BURNETT, M.D. specializes in Dermatology Physician and practices in SANTA BARBARA, California. Credentials: M.D..
How much does MARK BURNETT, M.D. prescribe under Medicare Part D?
In 2023, MARK BURNETT, M.D. wrote 364 Medicare Part D claims totaling $59K in drug costs for 191 beneficiaries.
What is MARK BURNETT, M.D.'s Medicare quality score?
MARK BURNETT, M.D. has a CMS MIPS Final Score of 72.6626/100 (Quality: 92.1536, Cost: 19.337). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MARK BURNETT, M.D. located?
MARK BURNETT, M.D. is located at 2323 OAK PARK LN STE 202, SANTA BARBARA, CA, 93105. Phone: (805) 892-8111.
What is MARK BURNETT, M.D.'s NPI number?
MARK BURNETT, M.D.'s National Provider Identifier (NPI) is 1104182393, issued on 04/02/2012.
Does MARK BURNETT, M.D. prescribe more brand-name or generic drugs?
MARK BURNETT, M.D.'s prescribing is 4% brand-name and 96% generic drugs by claim count, with $50K in brand drug costs.
Does MARK BURNETT, M.D. prescribe opioids?
Yes, MARK BURNETT, M.D. had 27 opioid claims in 2023 with an opioid prescribing rate of 7.4%.
How many Dermatology Physician providers are there in the US?
There are 14,610 Dermatology Physician providers across 53 states in the US. The average Dermatology Physician provider writes 729 Medicare Part D claims per year.
What drugs does MARK BURNETT, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MARK BURNETT, M.D.'s most frequently prescribed drugs include Mupirocin, Clobetasol Propionate, Triamcinolone Acetonide. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK BURNETT, M.D. accept Medicare?
MARK BURNETT, M.D. appears in CMS Medicare data with 364 Part D claims and 191 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK BURNETT, M.D.'s credentials?
MARK BURNETT, M.D.'s NPI is 1104182393 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology